TipRanks
Go Ultimate55% OFF

CARsgen Therapeutics Holdings Ltd. (CRTHF) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

CRTHF Analyst Ratings

Moderate Sell
1Ratings
0Buy0Hold1Sell
Based on 1 analysts giving stock ratings to CARsgen Therapeutics Holdings Ltd. in the past 3 months

CRTHF Stock 12 Month Forecast

$1.76▲(8.73% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for CARsgen Therapeutics Holdings Ltd. in the last 3 months. The average price target is $1.76 with a high forecast of $1.76 and a low forecast of $1.76. The average price target represents a 8.73% change from the last price of $1.62.
Highest Price Target$1.76Average Price Target$1.76Lowest Price Target$1.76

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CRTHF
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
Goldman Sachs Analyst forecast on CRTHFUnknown AnalystNot RankedGoldman Sachs$2.05→$1.76sell8.73%UpsideReiterated08/20/26
UBS Analyst forecast on CRTHFUnknown AnalystNot RankedUBS$3.28buy102.20%UpsideReiterated06/22/26
TFI Asset Management Analyst forecast on CRTHFUnknown AnalystNot RankedTFI Asset Management$3.71buy128.79%UpsideReiterated01/13/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CARsgen Therapeutics Holdings Ltd.

3 Months
DeepSeek Health Care HK
DeepSeek Health Care HKTipRanks - DeepSeek
Success Rate1/2 ratings generated profit
50%
Average Return
-8.80%

Copying DeepSeek Health Care HK's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -8.80% per trade.

1 Year
DeepSeek Health Care HK
DeepSeek Health Care HKTipRanks - DeepSeek
Success Rate1/2 ratings generated profit
50%
Average Return
-8.80%

Copying DeepSeek Health Care HK's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -8.80% per trade.

2 Years
DeepSeek Health Care HK
DeepSeek Health Care HKTipRanks - DeepSeek
Success Rate1/2 ratings generated profit
50%
Average Return
-8.80%

Copying DeepSeek Health Care HK's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -8.80% per trade.

CRTHF Analyst Recommendation Trends

00.511.52Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for CRTHF
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy11000
Buy00000
Hold00000
Sell01110
Strong Sell00000
total12110

In the current month, CRTHF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CRTHF average Analyst price target in the past 3 months is 1.76.

CRTHF Financial Forecast

$-2$-1.5$-1$-0.5$0Q2 2025Q2 2026Q4 2026
High$-0.02
Consensus$-0.02
Low$-0.02

CRTHF Earnings Forecast

Next quarter’s earnings estimate for CRTHF is -$0.02 with a range of -$0.02 to -$0.02. The previous quarter’s EPS was -$0.02. CRTHF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CRTHF has Performed in-line its overall industry.

$4.6M$11.3M$18.1M$24.8M$31.6MQ2 2025Q2 2026Q4 2026
High$31.6M
Consensus$31.6M
Low$31.6M

CRTHF Sales Forecast

Next quarter’s sales forecast for CRTHF is $31.59M with a range of $31.59M to $31.59M. The previous quarter’s sales results were $9.00M. CRTHF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CRTHF has Performed in-line its overall industry.

CRTHF Stock Forecast FAQ

What is CRTHF’s average 12-month price target, according to analysts?
Based on analyst ratings, CARsgen Therapeutics Holdings Ltd.’s 12-month average price target is $1.76.
What is CRTHF’s upside potential, based on the analysts’ average price target?
CARsgen Therapeutics Holdings Ltd. has 8.73% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CRTHF a Buy, Sell or Hold?
CARsgen Therapeutics Holdings Ltd. has a consensus rating of Moderate Sell which is based on 0 buy ratings, 0 hold ratings and 1 sell ratings.
What is CARsgen Therapeutics Holdings Ltd.’s price target?
The average price target for CARsgen Therapeutics Holdings Ltd. is $1.76. This is based on 1 12-month price targets, issued in the past 3 months. The highest analyst price target is $1.76, the lowest forecast is $1.76. The average price target represents a 8.73% increase from the current price of $1.62.
What do analysts say about CARsgen Therapeutics Holdings Ltd.?
CARsgen Therapeutics Holdings Ltd.’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of CRTHF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.